29,903,300 € (the amount may include granted donations not yet published)
Convergence of humans and machines. 6 years.
Research Centre for Ecological Change. 5 years.
Advanced steels for a green planet. 5 years.
Discovery of precision immunotherapies for blood cancers. 4 years.
Towards precision immunotherapy for malignant glioma. 4 years.
Multiscale assessment of epileptogenicity in the human brain – for better diagnosis and treatment of drug-refractory epilepsy. 3 years.
Finnish National Ballet Youth Company. 3 years.
Unraveling the genesis of uterine leiomyoma. 5 years.
Gut microbiota driving chronic disease risk during the life-course. 4 years.
Development of sustainable technologies for electrical energy storage based on biomaterials and 3D printing (SUSTEC). 4 years.
Phenomena maps: development initiative for improving the societal impact of research evidence.
Drilling down the mechanisms linking mitochondrial fatty acid synthesis to nutritional state signaling and human disorders. 4 years.
Impact of cellular structures on nuclear egress of herpesvirus capsids. 3 years.
Human collagen prolyl 4-hydroxylase: structural enzymological understanding and drug discovery research for fibrotic diseases and cancer. 4 years.
Improved diagnostics and therapeutic options for neuromuscular disorders. 3 years.
Necrotizing fasciitis – from genetic errors to molecular pathogenesis and targeted treatment. 3 years.
The rogue satellite? – Cross-species transmission potential and disease associations of kolmiovirids. 5 years.
Myelin plasticity in anxiety disorders. 4 years.
Development of optogenetic technologies for cancer research and therapy. 3 years.
Exploring microglia and astrocyte-driven pathology in multiple sclerosis using multimodal MRI and PET imaging. 5 years.
Novel imaging methods for evaluating bone and cartilage repair. 4 years.
Machine Learning surrogate modeling for risk assessment and water quality prediction at mining sites. 4 years.
Unraveling the developmental mechanisms underlying craniofacial diversity and disease. 3 years.
Functional Omics for Network-based Drug Combination Therapy: Integration of Thermal Proteome Profiling and Deep Metabolomics. 4 years.
An ultrasonic method to overcome shortcomings of ex vivo gene therapies. 3 years.
Towards sustainable metal economy: designing interfaces to stabilize two-dimensional metals. 4 years.
Pluripotency Directed Cancer Fight. 2 years. Proof of Concept.
Ballet energy for children. 2 years.
XIII International Jean Sibelius Violin Competition 2025. 4 years.
Biomarker-based identification of cancer aggressiveness and design of individual cancer treatment. 2 years. Proof of Concept.
Development of international sales and marketing of dance and circus, production and touring activities and increase of knowledge capital. In cooperation with the Zodiak – Centre for New Dance, the Cirko – Centre for New Circus and the Dance House Helsinki. Proof of Concept. 1–2 years.
Enigmatic toxin-antitoxin systems in Mycobacterium tuberculosis – what do they do, are they druggable? 2 years.
Turku Music Festival presents three major international artist icons in 2023. 1,5 years.
Can Desulfovibriobacteria cause α-synuclein aggregation leading to Parkinson´s disease? 2 years. Proof of Concept.
Germline epigenome in the maintenance of male fertility and transgenerational offspring health. 2 years. Proof of Concept.
International orchestra visits at the Mikkeli Music Festival.
Amelioration of Alzheimer’s disease symptoms by restoring the function of parvalbumin-positive interneurons. 3 years.
V International Uuno Klami Composition Competition 2023–2024.
Running Relay for Finnish schools on Olympic Stadium 2022.
J. H. Erkko writing contest 2022.
Stipends 2022.